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SUMMARY
This study evaluated the spatio-temporal variation of Legionella spp. in New Zealand using
notification and laboratory surveillance data from 1979 to 2009 and analysed the epidemiological
trends. To achieve this we focused on changing incidence rates and occurrence of different species
over this time. We also examined whether demographic characteristics such as ethnicity may be
related to incidence. The annual incidence rate for laboratory-proven cases was 2.5/100 000 and
1.4/100 000 for notified cases. Incidence was highest in the European population and showed
large geographical variations between 21 District Health Boards. An important finding of this
study is that the predominant Legionella species causing disease in New Zealand differs from that
found in other developed countries, with about 30–50% of cases due to L. longbeachae and a
similar percentage due to L. pneumophila for any given year. The environmental risk exposure
was identified in 420 (52%) cases, of which 58% were attributed to contact with compost ; travel
was much less significant as a risk factor (6.5%). This suggests that legionellosis has a distinctive
epidemiological pattern in New Zealand.
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INTRODUCTION
Legionellosis is a collective term for the clinical syn-
dromes caused by members of the genus, Legionella.
Legionellae are intracellular protozoan parasites
found ubiquitously in both water and moist soil en-
vironments and have been isolated globally from these
habitats. A number of human-made environments, in
particular air-conditioning systems and water-
distribution systems, have been found to act as
reservoirs and amplifiers of Legionella [1–3] producing
and dispersing aerosols. They form a critical part of an
effective pathway of transmission for Legionella and
are a frequent source of human exposure. Other
opportunities for human exposure to Legionella have
been identified from soil, composts and potting mix
[3]. Although this transmission route is not fully under-
stood it is likely to involve aerosolized dust particles
containing Legionella.
Legionella is associated with two distinct clinical
illnesses : Pontiac fever, a non-pneumonic, self-
limiting influenza-like illness of typically 2–5 days’
duration following an incubation period of 5–72 h [4] ;
and Legionnaires’ disease (LD) which is characterized
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by atypical pneumonia with an incubation period of
2–10 days and carries a fatality rate of 10–15% in
otherwise healthy individuals [5]. Both Pontiac fever
and LD fit a spectrum of illness that occurs as a result
of environmental exposure to Legionella [6]. Since
1976, at least 50 species of Legionella have been
identified, 20 of which have been associated with
human infection [7]. Globally Legionella pneumophila
serogroup 1 (Lpsg1) is the most common type known
to cause disease [8]. Predisposing risk factors for
legionellosis include smoking, advanced age (o65
years), male sex and the existence of pre-existing
chronic pulmonary disease, diabetes, renal failure or
any illness or treatment associated with immuno-
suppressive conditions. Cases have been reported in all
age groups in otherwise healthy individuals including
infants [9]. Contact with a contaminated environmen-
tal source is a necessary precursor for infection along
with predisposing host factors that are not fully
understood. To date, there have been no documented
cases of person-to-person transmission of the bacteria
[10] and it is deemed non-communicable.
Legionellosis occurs worldwide with a number of
outbreaks described globally [8]. Legionella infections
may be sporadic or epidemic, occurring most fre-
quently worldwide as sporadic cases, either noso-
comial (hospital) or community acquired [8], with
significant variation between countries. For example,
studies from Europe and North America showed the
incidence of Legionella as a cause of all sporadic
community-acquired pneumonias ranged from 2% to
15% [11]. A study carried out in New Zealand in the
mid-1990s estimated the percentage of cases of com-
munity-acquired pneumonia caused by Legionella to
be 2–11% [12].
The first known case of legionellosis inNewZealand
was diagnosed in 1979 [13] and by the end of
December 2009, 1461 cases had been notified.
New Zealand appears to have a relatively high annual
incidence rate of LD of 1.4/100 000 population
(1980–2009) compared to other developed countries.
This high incidence rate is possibly due to New
Zealand’s long history of laboratory-based surveil-
lance through a centralized reference laboratory
established in 1979, for diagnosing and reporting
cases.
The patterns of Legionella spp. and serogroups as-
sociated with the disease in New Zealand are different
to those seen in most other developed countries where
L. pneumophila causes 90% of illness, with Lpsg1
alone accounting for about 85% of cases [14]. In
New Zealand L. longbeachae, a species associated
with exposure to compost and gardening potting mix
[15] is the causative agent for as many as 50% of
community-acquired sporadic cases [16]. This makes
the New Zealand situation worthy of investigation
and of global interest.
Disease surveillance in New Zealand shows legio-
nellosis outbreaks are rare and that the majority of
these infections are sporadic cases of community-
acquired pneumonia where L. pneumophila accounts
for about 50% of cases [15]. This is different to a
country like the USA where Lpsg1 makes up 90% of
Legionella case isolates [9].
Surveillance for legionellosis began in New Zealand
in 1979 with the availability of annual laboratory-
proven data and the addition of notification data from
1981 (legionellosis became notifiable in June 1980),
yet there has been a paucity of published research
focusing on the epidemiology of legionellosis in New
Zealand. Publications to date have tended to be brief
descriptive epidemiological summaries of data for
1 year only [17, 18]. This paper provides the first
comprehensive epidemiological review of legionellosis
in New Zealand since 1979 when the first case was
diagnosed. Our objectives were to examine the diver-
sity of Legionella spp. causing disease in New Zealand
and to evaluate the spatial and temporal variation
over the past three decades. By analysing the chang-
ing epidemiological trends of legionellosis in New
Zealand, this evaluation will inform the epidemiolo-
gical picture at the global level, and provide additional
information for better public health control measures.
METHODS
Surveillance of legionellosis
In New Zealand legionellosis surveillance (including
LD and Pontiac fever cases) consists of both labora-
tory and disease notification data collected for public
health purposes. However, the epidemiology of
Pontiac fever in New Zealand, as with other jurisdic-
tions, is not as well characterized as LD due to
Pontiac fever being relatively benign and frequently
not requiringmedical invention [4]. Because of this it is
suspected most cases of Pontiac fever in New Zealand
are unreported. Legionellosis has been notifiable in
New Zealand since June 1980. Notifications are made
to the local Medical Officer of Health, a statutory
position under the Health Act 1956. Health profes-
sionals and all medical laboratories (since December
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2007) are required to inform their local Medical
Officer of Health of any case of legionellosis.
Historical notification data for the years 1980–1995
were obtained from the Institute of Environmental
Science and Research Ltd (ESR), records obtained
from the New Zealand National Archives and annual
reports of the then Department of Health. Most of the
analysis from 1996 was based on aggregated annual
legionellosis surveillance and outbreak data collated
by ESR. Since 1996 ESR has operated and managed
a national notifiable disease surveillance database,
EpiSurv7 [19], under contract to the Ministry of
Health. Key data fields collected include case demo-
graphics, clinical features, laboratory identification of
the causative agent and risk factors. Similar data for
laboratory-identified environmental isolates have
been collected since 1987.
The annual incidence rates for New Zealand were
calculated by dividing the number of notified cases for
each year by the mid-year population estimates and
the results were expressed as cases per 100 000. The
mid-year population estimates were sourced from
Statistics New Zealand which conducts a census of
population every 5 years. In circumstances where mid-
year population estimates were unavailable for a par-
ticular variable (e.g. age and sex distribution), the
census data were interpolated from the 5-yearly
national population census for the years 1981, 1986,
1991 and 1996 to obtain mid-year estimates. Where
fewer than five cases annually were notified a rate was
not calculated.We also calculated the case-fatality rate
where legionellosis is recorded as the primary cause on
the death certificate, as a measure of disease severity.
All notification data were aggregated to the same
21 New Zealand District Health Boards’ (DHBs) and
were compared using consistent geographical units
(2001 boundaries) over time. The DHBs are respon-
sible for the provision of health and disability services
in each region. The Boards have a mean population
size of 201 000 and range from 32000 (largely rural) to
513 000 (metropolitan).
Case definition and testing methods
Since LD has no clinical features that easily dis-
tinguish it from other severe respiratory diseases, it
can only be diagnosed definitively by an appropriate
laboratory test. The current case criteria (that was
developed in 1998 and is now under review) for a
‘confirmed’ legionellosis case is compatible clinical
disease and either culture isolation of any Legionella
spp. from respiratory secretions, lung tissue, pleural
fluid, or any normally sterile site, or the dem-
onstration of the presence of Legionella spp. by the
direct fluorescence antibody (DFA) test in respiratory
secretions, lung tissue or pleural fluid, or the demon-
stration of either at least a four-fold rise in Legionella
antibody titre to at least 256 in sera, or the demon-
stration of elevated titres of >256 in convalescent-
phase sera [20]. A case is reported as ‘probable’
when a patient has clinically compatible symptoms
and a single convalescent-phase serum antibody
titre of >256 [20]. Until 1988 a cut-off of 128 was
used in the Legionella indirect fluorescent antibody
(IFA) test following seroprevalence studies carried
out initially in 1980. The IFA cut-off was reassessed
in 1988 and increased to 256 and further reassessed
in 2005 with no change made. These studies used
cohorts of healthy blood donors and acute
admissions to a public hospital for any cause to de-
termine the level of Legionella-specific antibodies in
these cohort populations and to determine the ap-
propriate cut-off antibody titres for the Legionella
IFA test [21].
More recent testing methodologies such as the
Legionella urinary antigen test (UAT) or the demon-
stration of Legionella-specific nucleic acid in clinical
specimens using nucleic acid amplification techniques
(NAAT), including PCR, are becoming more widely
used but are yet to be officially adopted for New
Zealand case definition for notification purposes
[22]. The Ministry of Health is currently reviewing
the laboratory criteria for diagnosis of legionellosis
which will include other diagnostic tests such as
the UAT and NAAT. The UAT is considered suf-
ficiently robust and will be included in the revised
confirmed case criteria, whereas a positive NAAT
test is likely to remain as criteria for a probable case
only.
Serum samples sent to the Legionella Reference
Laboratory for confirmatory testing are tested by IFA
against a panel of heat-killed whole-cell Legionella
antigens that include L. pneumophila serogroups 1–15,
L. anisa, L. bozemanae, L. dumoffi, L. feeleii, L. gor-
manii, L. jordanis, L. longbeachae, L. micdadei,
L. oakridgensis and L. sainthelensi [18]. All of these
species and almost all of these serogroups have
been isolated from clinical specimens over the last
30 years.
The Legionella Reference Laboratory can receive
up to three specimen types for each case : sera, res-
piratory tract samples and Legionella culture isolates.
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Serum is the predominant specimen type with almost
all laboratory-proven cases having supporting serol-
ogy results. The remaining cases are either culture-
positive, NAAT test positive or positive by UAT,
with some cases testing positive for Legionella using
more than one test.
Both ‘confirmed’ and ‘probable’ cases under the
current case definition have been included in this
paper, with the addition that all clinically compatible
cases with a positive Legionella UAT test have been
included as ‘confirmed’ cases while those with clini-
cally compatible disease and only a positive Legionella
PCR test have been included as ‘probable’ cases. All
laboratory-proven legionellosis cases meeting the
above case definition and notified between 1 June 1980
and 31 December 2009 have been included in the
analysis.
Demographic characteristics
New Zealand is a country with an ethnically diverse,
ageing and geographically mobile population of
just over 4 million. In 2006 the European ethnic
group accounted for 69%, Maori 15%, Asian 9%
and Pacific Peoples 7% of the total population [23].
As in other developed countries New Zealand’s pro-
portion of older population (o65 years) is increasing.
Cases of self-reported ethnicity are recorded in
EpiSurv and entered onto the database by local public
health unit staff of DHBs who are investigating noti-
fied cases. To account for the fact that more than
one ethnicity can be recorded in the legionellosis
case report form and in the census form, Statistics
New Zealand’s ‘prioritized ethnicity ’ concept for
both numerator and denominator was used [24]. In
circumstances where a multiple response is given,
the prioritization of ethnic group data assigns each
person to just one group. Four prioritized ethnic
groups were used in this analysis : Maori, Pacific
people (Samoan, Cook Island, Tongan, Niuean,
Fijian, Tokelauan, Tuvalu Islander), European
(New Zealand and other European combined),
‘Other ’ (Asian, Latin American, Middle Eastern,
African). Age-standardized rates were directly age-
standardized to the World Health Organization
population.
Legionellosis outbreaks
Outbreaks are defined as two or more cases associated
with a single site of exposure with dates of onset
within 6 months of each other [20]. Data on legio-
nellosis outbreaks reported since 1990 were obtained
from ESR. Outbreaks were analysed by monthly
distribution, DHB area, outbreak source, Legionella
spp. and serogroup and number of confirmed cases
and deaths.
Statistical analysis
Poisson regression was used to estimate the incidence
rate ratios (IRR) for legionellosis in population age
and ethnicity groups. Statistical analyses were per-
formed using SPSS version 15 (SPSS Inc. USA) and
thematic maps were created using ArcGIS version 9.3
(ESRI, USA).
RESULTS
A total of 2772 cases of legionellosis fitting the
case definition were laboratory-proven between 1979
and 2009 giving a mean annual incidence rate of
2.5/100 000. Of these 1313 (47.4%) fitted the criteria as
a ‘confirmed’ case and 1459 (52.6%) as ‘probable’
case (Fig. 1). A total of 1461 (53%) of the laboratory-
proven cases were notified giving a mean annual noti-
fication incidence rate of 1.4/100 000. Figure 2 shows
the laboratory-proven cases of legionellosis by year
since 1979 and notified cases since 1980. Prior to direct
laboratory notification to Medical Officers of Health
of legionellosis in 2007, notification rates for labora-
tory-proven cases were poor with only about 50% of
cases notified. The year 2000 marked the first occasion
that the total number of notified cases exceeded that of
laboratory-proven cases acknowledging a heightened
awareness among clinicians and the fact that in some
circumstances a lack of de-notification of cases, i.e.
cases notified on suspicion, that were not confirmed
through diagnostic testing. The cut-off in the sero-
logical test was adjusted in 1989 because of a high
number of positive tests between 1985 and 1988. Since
1999 there has also been closer scrutiny and reciprocal
matching of both laboratory-proven and notified cases
resulting in total cases for each year being more closely
aligned.
Risk factors
The total number of laboratory-proven cases re-
corded in the EpiSurv database between 1997 (when
data became available) and 2009 was 805. An en-
vironmental exposure risk was reported for 420
(52%) of these cases. For 243 (30%) cases contact
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with compost/potting mix or soil during their incu-
bation period was identified (Table 1a). For a further
16% of cases exposure to either showers/hot-water
systems, spa/indoor pools, air-conditioning units and
using a water blaster was identified. More than one
potential exposure risk was recorded for a small pro-
portion of cases. Fifty-two (6.5%) of the total number
of reported cases had a history of overseas travel
during the incubation period. Table 1b confirms that
as with other jurisdictions smoking and the existence
of a pre-existing immunosuppressive or debilitating
condition are predisposing risk factors for legio-
nellosis [9].
Figure 3 shows the number of Legionella
strains identified for the clinical laboratory-proven
legionellosis cases from 1979 to 2009. L. pneumophila
and L. longbeachae accounted for over 50% of the
laboratory-proven cases. Other than for 1987 and
1988 when a lower serological cut-off value was used,
the results show a significant proportion of cases
caused by L. longbeachae since 1999.
Between 1987 and 2009, 1471 environmental iso-
lates of Legionella have been laboratory identified
with most identified to the species level. Figure 4
shows that there is a diversity of pathogenic and non-
pathogenic species and serogroups that have been
routinely isolated from the environment including
water sources (i.e. air conditioners, cooling towers,
whirlpool spas, showers) and compost/potting mix/
soil contaminated with the bacteria. Most of these
isolates are from environmental sites implicated as the
source of infection for a case and as such show the
diversity of strains to which the general population
are exposed. While Lpsg1 is prominent among the
L. pneumophila isolates, other serogroups include
Lpsg 5 and Lpsg 6 that were seen in significant
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Fig. 2. Legionellosis notifications and laboratory-proven cases by year, 1979–2009.
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Fig. 1. Laboratory-proven cases fitting confirmed (&) and probable ( ) case definition by year, 1979–2009.
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numbers in clinical cases in the 1980s [25]. L. long-
beachae is also another prominent species isolated
from the environment and again reflects the pre-
dominance of this strain in clinical cases. Where the
species or serogroup could not be clearly identified
due to an antibody cross-reaction or a positive reac-
tion to more than one species in the DFA test, it has
been recorded as ‘Unidentified’ Legionella spp.
Regional distribution
Figure 5 shows rates of notified legionellosis by DHB
(divided into five quintiles based on mean rate/100 000
population) for 1981–1990 and 2000–2009. The two
highest quintiles (with the darkest shading) were
above the mean national notifiable incidence rate (1.4
cases/100 000 population). Consistently high rates
were seen in the Hutt Valley (2.9/100 000 population,
1981–1990 and 2.3/100 000 population, 2000–2009)
and Capital & Coast (4.3/100 000 population,
1981–1990 and 2.2/100 000 population, 2000–2009)
DHBs which are situated in the lower North Island
(data shown in Appendix Table A1).
Demographic characteristics
The age of laboratory-proven confirmed cases ranged
from <12 months to 101 years with a median age
of 57 years (Fig. 6). Age-standardized rates show
that the rate of infection increased almost pro-
portionally with age, with the highest rate occurring
in the 50–59 years age group. Males generally showed
higher rates than females with an overall ratio of
1.7:1 except in the 30–39 years age group where
female rates were higher than males. Sixty-four deaths
were reported between 1980 and 2009, giving an
overall case-fatality rate of 5.1% (range 27% to 2%)
(Fig. 7). High case-fatality rates were recorded in 1982
and 1996. The high case-fatality rate in 1982 may
have resulted from under-reporting of cases with three
deaths occurring in the 11 laboratory-proven cases.
Age-standardized rate of legionellosis for
European, Maori, Pacific and Other ethnicities are
shown in Table 2. Ethnicity data was only available
from 1996 and the actual number of confirmed cases
and age-incidence rates of the four ethnic groups are
shown in Appendix Table A2. The dataset was
Table 1a. Environmental risk exposures associated with legionellosis
1997–2009
Risk factor identified Yes Proportion* No.#
Environmental source 368 (46%) 88% 437
Compost$ 243 (30%) 58%
Water· 125 (16%) 30%
Overseas travel during
incubation period
52 (6.5%) 12% 753
Total cases (805) 420 (52%) 100% 385
* ‘Proportion’ refers to the percentage of cases that answered ‘yes’ out of the total
number of cases with a known risk exposure.
# Refers to cases where risk was not determined or data was unavailable.
$ Including exposure to potting mix, mulch, or soil within 10 days prior to onset of
disease.
· Including exposure to potable water systems, spa/indoor pools, cooling towers or
water blasters within 10 days prior to onset of disease.
Table 1b. Personal risk factors associated with legionellosis 1997–2009
Risk factor Yes No Proportion* Unknown#
Smokers or ex-smokers 160 493 25% 152
Pre-existing immunosuppressive
or debilitating condition$
237 392 38% 176
* ‘Proportion’ refers to the percentage of cases that answered ‘yes’ out of the total
number of cases for which this information was recorded.
# Refers to circumstances in which the data was unavailable.
$ Includes diabetes, chronic lung disease, cancer, transplant recipient and corti-
costeroid treatment.
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divided into two 7-year periods (1996–2002 and
2003–2009) to ascertain whether there was any dif-
ference in incidence rates. The age-standardized rates
increased slightly for all ethnicities over the two
7-year periods. The IRR also showed very little fluc-
tuation with a slight increase in Pacific people.
Seasonal distribution
National surveillance data between 1980 and 2009
consistently showed an increase in incidence of
legionellosis during the late spring (September–
November) and autumn (March–May) months,
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possibly representing increased exposure related to
outdoor activities such as gardening and the use of
compost (Fig. 8). This is reflected in a seasonal spike
in cases caused by L. longbeachae often seen in spring.
Outbreaks
Since 1990, 14 recorded outbreaks of legionellosis
were identified (Table 3). There were no legionellosis
outbreaks for laboratory-proven cases from 1991 to
1996 and in 2000, 2004, 2008 and 2009. L. pneumo-
phila, L. longbeachae and L. dumoffii were identified as
the most likely causes of these outbreaks. These out-
breaks included a total of 70 cases since 1990. Either
compost material or cooling towers were identified as
the source for 66% of legionellosis outbreaks. The
number of outbreaks is small and each involves
low numbers of cases. Compost material has been
identified as the environmental risk source in more
outbreaks than cooling towers (five associated with
compost compared to three associated with cooling
towers). Although the case definition for an outbreak
spans a 6-month time period for cases with exposure
to the same environmental source, this has not
impacted on the outbreak data due to none of the
identified outbreaks involving cases separated in time
by more than a month.
DISCUSSION
This study used a combined dataset of legionellosis
laboratory-proven and notified cases to give a
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comprehensive assessment of the epidemiology of this
disease in New Zealand. To our knowledge this rep-
resents the longest time-series of legionellosis cases
for a country in the medical literature. Previously
published analyses of legionellosis epidemiology of a
similar duration have been restricted to a particular
country’s province and evaluated laboratory-proven
cases only [26].
This analysis of routinely collected data suggests
that New Zealand has a higher rate of legionellosis
than some other developed countries of similar tem-
perate climate. Even when the probable cases are
excluded from the total number of New Zealand
laboratory-proven cases, the reported incidence of
disease of 0.4/100 000 population for laboratory-
confirmed cases was just slightly less than the USA of
0.5/100 000 population for the total number of cases
reported for the same time period 1979–2009 [27].
Notified case numbers alone do not represent the
true situation with legionellosis in New Zealand. This
is demonstrated by the differences observed between
health districts (although they range in population
Table 2. Legionellosis case number and incidence rate by ethnicity, New Zealand, 1996–2002 and 2003–2009
1996–2002 2003–2009
Ethnic group Cases Pop. Rate* IRR 95% CI Cases Pop. Rate* IRR 95% CI Total cases
European 268 2 323 101 1.2 Ref. 390 2 285 667 1.7 Ref. 658
Maori 16 526 275 0.8 0.27 0.16–0.43 22 563 091 1 0.25 0.16–0.38 38
Pacific 5 200 247 0.7 0.08 0.03–0.20 13 226 296 1.2 0.15 0.08–0.26 18
Other 9 400 329 0.5 0.15 0.08–0.29 16 952 527 0.8 0.18 0.11–0.30 25
IRR, Incidence rate ratio ; CI, confidence interval.
* Age-standardized rate per 100 000 standardized to the New Zealand population-age structure of the 2001 and 2006 census
and World Health Organization standard population.
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size and are either predominantly metropolitan or
rural). The marked difference in the number of noti-
fications for the Wellington region during the 1980s
compared to other health districts should not be
interpreted as being due to a greater incidence locally.
Rather, it probably reflected the readiness of clin-
icians to consider and establish the diagnosis, the
local availability of serology testing and laboratory
staff examining any pertinent serum samples referred
for serology [28]. Conversely, the higher incidence
rates in the eastern regions of the North Island
namely Tairawhiti regions and South Island
(Canterbury region) may well be reflective of the
thriving horticultural industry and consequent wide-
spread use of potting mix and compost as well as a
warm and temperate climate (in New Zealand tem-
peratures rarely fall below x10 xC in inland alpine
areas or rise above 30 xC). For example, between 2000
and 2009 of the 167 laboratory-confirmed cases of
L. longbeachae reported, 38.3% originated in these
regions. The Tairawhiti region had the highest
reported L. longbeachae annual incidence rate of
13.0/100 000 population followed by Canterbury (9.9/
100 000 population).
The increasing number of cases proven in New
Zealand each year since 1979 is probably attributable
to two factors. First, an increasing awareness among
physicians resulting in an increase in the number of
specimens submitted to the national laboratory and
second, the expansion of the battery of antigens used
in the serology testing during the 1980s leading to an
increasing number of positive cases. For example, up
to August 1982 the antigens available were restricted
to L. pneumophila serogroups 1–4. The battery of
antigens were expanded to include L. pneumophila
serogroups 5 and 6, L. bozemanae, L. dumoffii,
L. gormanni, L. jordanis, L. longbeachae sg1 and
L. micdadei by 1985 [29]. L. sainthelensi was added in
2008 following clinical isolation from two cases in
2007. There was not the full understanding of the IFA
test specificity and sensitivity prior to 1988 with a
lower cut-off value being used to determine positivity.
In addition, some patients showing reactivity to
multiple Legionella antigen pools in the IFA test were
regarded as a positive case rather than a non-specific
cross-reaction. This interpretation of the serology
results has inflated case numbers in these years. For
example in 1987 where a total of 276 patients were
reported ‘presumptive positive ’ on the basis of a
single elevated antibody titre>128, using the current
cut-off values about 50% of these would not fit the
criteria to be regarded as a case.
The high case-fatality rate observed in 1982 has
resulted from investigating the cause of death for
these patients against a background of a low number
of positive cases. The low number of positive cases
Table 3. Recorded outbreaks of legionellosis, New Zealand since 1990
Year Month Location Likely source Species and serogroup
No. of cases
(confirmed)
No. of
deaths
1990 Feb. Christchurch Cooling tower L. pneumophila sg1 4 0
1997 Oct. Wellington Hot-water system L. pneumophila sg1 3 0
1998 Mar. Hastings Internal water system L. pneumophila sg1
and sg5#
11 1
2001 Jan. Auckland Cooling tower L. dumoffii 2 0
2001 Feb. Whangarei Commercially prepared
composted material
L. longbeachae sg1 2 0
2002 Dec. Auckland Display spa pool L. pneumophila sg2 3 0
2003 Oct.–Nov. Wellington Display spa pool L. pneumophila sg2 3 0
2003 Oct.–Nov. Wellington
(Upper Hutt)
Composting facility L. longbeachae sg1 4 0
2003 Nov. Auckland Compost L. longbeachae sg1 2 0
2003 Dec. South Auckland Compost L. longbeachae sg1 2 0
2005 Apr.–Aug. Christchurch Cooling tower L. pneumophila sg1 19 3
2005 July Christchurch Domestic spa pool L. pneumophila sg1 2 0
2006 Feb.–Mar. Beachlands, Auckland Contaminated
rainwater tanks*
L. pneumophila sg1 4 1
2007 Jan. Gisborne Potting mix L. longbeachae sg2 9 0
* Possibly from aerosols containing Legionella discharged into air from a marina water blaster [42].
# Possibly Pontiac fever [18].
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that year is the result of low awareness of the avail-
ability of Legionella testing and the limited range of
antigens available for testing either using DFA or
IFA [29].
By 1985 New Zealand was testing against 11 dif-
ferent Legionella spp. out of the 14 known pathogenic
species at that time [29]. This is reflected in the high
number of confirmed cases for 1985 and 1986. During
that same year there was considerable increase in in-
terest in legionellosis possibly as a result of its high
political profile when L. pneumophila was identified in
the air-conditioning system in the New Zealand
Parliamentary Executive building. This resulted in the
publication in 1987 of The Code of Practice for the
Control of Hygiene in Air and Water Systems in
Buildings (New Zealand Standard 4302:1987) aimed
at reducing the risk of Legionella in building water
systems and updated in 2002 through building legis-
lation. Such a change may have contributed to a re-
duction in legionellosis risk observed during the last
two decades although there is empirical evidence that
cooling towers are key contributors to sporadic cases
[3, 8].
The marked increase in the number of laboratory-
proven cases in 1987 was attributed to the increase
in the number of hospital laboratories offering
Legionella testing services. This followed the intro-
duction at the National Health Institute (now ESR) in
1988 of Legionella serology training courses and to an
intensive public health education programme [28].
However, the large numbers of laboratory reported
cases for 1987 and 1988 is likely due to an over-
estimation of the number of actual cases due to the
interpretation of the antibody titre, i.e. different
criteria being used to ascertain whether a case was
positive or not. Prior to 1988 there were three cat-
egories – negative, probable or confirmed. Probable
cases included those with elevated antibody titres in
more than one antigen pool which may have resulted
in the observed increase in incidence.
Since 1990 four categories have been used – nega-
tive, inconclusive, probable and confirmed. These are
based primarily on serological findings for one or
more serum samples from each case. A case is deemed
‘serologically negative ’ when antibody titres in paired
sera collected at least 3 weeks apart remain stable and
f256. A case is deemed ‘probable ’ when an elevated
antibody titre >256 is seen in one antigen pool and
shows a clear serotyping pattern to one Legionella
spp. for a single serum sample, or alternatively is
PCR-positive with no further laboratory evidence.
An ‘inconclusive’ result is based on elevated titres in
more than two antigen pools (usually indicating a
non-specific antibody cross-reaction in the IFA test),
or where there is an unclear serotyping result when
testing for the causative agent in the antigens of a re-
active antigen pool. This tightening of the interpret-
ation of serological titre results has led to a large
reduction in ‘probable’ cases. This is also reflected in
the large reduction of ‘unidentified’ species since 2000
(Fig. 3) due to surveillance data being significantly
more aligned. This observation has been reported in
other jurisdictions such as Denmark [30].
The results derived primarily from serological in-
vestigations suggest that the distribution of Legionella
spp. and serogroups do not necessarily follow pat-
terns observed in other jurisdictions globally. Indirect
evidence suggests that differences in diagnostic testing
procedures are not primarily responsible for these
observed patterns. For example, the uptake of diag-
nostic tests such as the urine antigen assay has not
been predominant in New Zealand since it only
detects Lpsg1. This is contrary to overseas where the
urine antigen assay has become the method of choice
for a diagnosis of Legionella infection and in some
cases has been included in the case definition by some
jurisdictions. As a result this has inadvertently caused
a decrease in the use of other diagnostic tests such as
culture to detect infection resulting in incomplete
surveillance for legionellosis in many countries [3].
The burden of legionellosis in New Zealand falls
most severely on older people although the import-
ance of Legionella spp. should be considered in all age
groups. Women in the <39 years age group rated
high in this analysis reflecting a trend towards
younger ages in recent times. This also highlights an
important misconception that LD is a disease of older
people that in turn may result in older people getting
preferential treatment at the expense of children and
younger people if it is not considered in the differen-
tial diagnosis [9]. The very small number of annual
deaths made case-fatality rates difficult to interpret
because they are subject to year-by-year variation.
Other demographic characteristics such as ethnicity
did not appear to affect the incidence rate of ethni-
cities other than European since it was observed
to be much higher in Europeans that in other
ethnicities possibly due to marked differences in life
expectancy.
Legionellosis cases due to L. longbeachae infection
form a significant number of those seen each year with
the first case reported in 1984 when serological testing
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for the organism began. As seen in Figure 3, in some
years cases caused by L. longbeachae are similar in
number or more than those caused by L. pneumophila
strains. This finding is similar to that seen in
Australia, but is not seen in other jurisdictions in
Europe and North America and suggests that the
L. longbeachae strains found in New Zealand and
Australia may be more virulent than strains else-
where. Alternatively gardening practices or compost
material may be intrinsically different, exposing more
people to the pathogen.
Legionellosis appears more common during
late spring and autumn months than at other times of
the year and is consistent with other Southern
Hemisphere jurisdictions, i.e. some Australian states
with a temperate climate, such as New South Wales
and Victoria, but not states with a tropical climate
[31]. This is also a similar characteristic of legio-
nellosis epidemiology in the Northern Hemisphere to
some degree; however, the seasonality appears to be
summer–autumn, possibly a reflection in recent years
of warmer and humid weather [32]. Such seasonal
trends in New Zealand may suggest a greater seasonal
influence on environmental reservoirs such as gar-
dening potting mix and compost which may influence
the degree of human risk [33]. Legionella populations
in cooling towers are also likely to be well established
after the summer period [31].
This analysis suggests that for New Zealand infec-
tion acquired abroad is not an important risk factor
compared to Europe where 13.8% of detected legion-
ellosis cases between 2000 and 2002 were linked to
travel abroad [34]. This is despite New Zealanders
having among the highest per capita international
travel rates in the world [35] with over 2 million resi-
dent New Zealanders departing New Zealand in 2008
[36]. The first confirmed case of travel-associated
legionellosis from abroad of a New Zealand resident
was reported in 1980 [37]. Of note were two travel-
associated cases confirmed in 2001 which were linked
to the largest documented legionellosis outbreak
in Australasia to date [38]. The reported source on
this occasion was a cooling tower at the Melbourne
aquarium, reflecting the popularity of Australia as a
destination for New Zealand tourists more than the
absolute risk of infection.
Most legionellosis infections in New Zealand occur
as sporadic cases and not in outbreaks. The first out-
break in 1990 was associated with a Christchurch
cooling tower [39] although it is possible that legio-
nellosis could have been responsible for an outbreak
of acute respiratory illnesses observed in June 1985 in
Wellington (New Zealand’s capital) [40]. In 1989 it
was postulated that the majority of Lpsg1 present in
New Zealand was not of the virulent Pontiac type
providing a possible explanation for the apparent
absence of outbreaks of LD [28]. However, results of
a survey of 11 cooling towers in buildings carried
out in 1998 in Wellington contradicted this. Water
samples from 8/11 cooling towers tested positive
for Lpsg1 Pontiac strain. Despite the small number of
samples, this survey indicated the significant presence
of this particular strain in the New Zealand environ-
ment [28].
Currently New Zealand’s largest outbreak occurred
in Christchurch in 2005 where the source once again
was thought to have been a cooling tower that re-
turned a positive result after spatial analysis identified
geographical clusters. The infecting organism in all
cases was Lpsg1 [41]. This outbreak also marked the
first occasion that sequence-based typing (SBT) was
used in New Zealand for the retrospective epidemio-
logical typing of Lpsg1 isolates from both clinical
and environmental sources associated with an out-
break [22]. The SBT profiles showed the same strain
of Lpsg1 isolated from cases had persisted in a par-
ticular cooling tower for the length of the outbreak
period. As a result SBT is rapidly becoming the
method of choice for typing Lpsg1 isolates in out-
breaks in New Zealand. In 2006 SBT was used again
to identify a possible source in an Auckland outbreak
where a marina water blaster may have seeded roof-
collected rainwater systems in a suburb some 4 km
away [42].
The first suspected outbreak of Pontiac fever in
New Zealand occurred during March 1998 in an office
building in Hastings although no clear causative
agent was identified [18]. In January 2007 the first
documented outbreak of Pontiac fever due to
L. longbeachae sg2 in potting mix was reported. This
outbreak would not have been apparent by legio-
nellosis UAT as it does not detect L. longbeachae. For
this reason it is suspected that the number of people
with Pontiac fever in areas with a high use of potting
mix may be underestimated [16].
One of the limitations associated with research of
this nature is that there is no universally accepted
clinical case definition for LD and Pontiac fever.
This means interpretation and comparison of sur-
veillance data from New Zealand with other countries
may be problematic because of the differences in
case definitions and types of surveillance systems.
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The opportunity to carry out surveillance using
an internationally consistent case definition has
been recognized by the New Zealand Ministry of
Health.
The use of routine notification data for monitoring
and surveillance can have limitations due to incom-
plete data on some variables, for example ethnicity
was not recorded in 104 (14.5%) of notified cases
(n=717) between 1996 and 2009. Moreover, because
we used the Statistics New Zealand prioritized eth-
nicity approach for both the numerator and denomi-
nator it is possible there were multiple responses.
While EpiSurv has been developed to record patient-
identified ethnicity this may not happen consistently,
particularly in a hospital setting where the person is
too ill to be interviewed by a health professional who
may gain their knowledge of the patient through the
front sheet of a hospital record.
CONCLUSION
Legionellosis remains an important cause of pneu-
monia in New Zealand and should continue to
be part of the differential diagnosis for any patient
admitted with severe pneumonia. While observed
legionellosis epidemiology was similar to that de-
scribed by other jurisdictions, the apparent high
incidence rate and wide diversity of Legionella spp.
identified from both clinical and environmental iso-
lates is suggestive that the epidemiology of legio-
nellosis in New Zealand is distinctive. Of particular
note are L. longbeachae infections which contribute
significantly to the number of sporadic cases annually
and have also been associated with a number of out-
breaks, including a large outbreak in 2007. While a
SBT system has been developed for Lpsg1 and has
been identified as a valuable epidemiological tool
for determining the genetic relatedness of these
strains in an outbreak setting, there are no similar
tools currently available for L. longbeachae. With
the recent publication of the complete genome se-
quence of a L. longbeachae isolate, this information
will be useful in the development of these typing
methods for this strain. The method would have util-
ity in the source-tracing of this particular species of
Legionella.
The advancement of test methodologies, our use
and interpretation of the results generated by them
and changing case definitions over the past 30 years
has influenced the epidemiological trends seen.
Comparisons with other jurisdictions must be
interpreted with caution due to differences in case
definitions and testing methodologies used.
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APPENDIX
Appendix Table A1. Legionellosis number and incidence rate by District Health Board, New Zealand, 1981–1990
and 2000–2009
District Health Board
1981–1990 2000–2009
Total Total
Number Rate Number Rate
Auckland 6 0.2 66 5.5
Bay of Plenty 1 0.1 47 4.1
Canterbury 61 1.7 103 9.1
Capital and Coast 93 4.3 44 2.2
Counties Manukau 7 0.3 58 5.1
Hawke’s Bay 19 1.4 21 1.9
Hutt Valley 38 2.9 30 2.3
Lakes 19 2.2 6 0.8
MidCentral 42 2.8 13 1
Nelson–Marlborough 8 0.8 12 1
Northland 40 3.4 26 2
Otago 23 1.3 26 1.9
South Canterbury 14 2.5 10 1.7
Southland 18 1.6 12 1.1
Tairawhiti 24 5.2 12 2.6
Taranaki 4 0.4 13 1.3
Waikato 13 0.5 46 1.9
Wairarapa 1 0.3 16 3.7
Waitemata 13 0.4 81 8.4
West Coast 0 0 9 2
Whanganui 10 1.5 7 1.2
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Appendix Table A2. Legionellosis number and incidence rate by ethnicity and age group, New Zealand, 1996–2002 and 2003–2009
Age group
(years)
European Maori Pacific People Other Ethnicity
1996–2002 2003–2009 1996–2002 2003–2009 1996–2002 2003–2009 1996–2002 2003–2009
No. Pop. Rate* No. Pop. Rate No. Pop. Rate No. Pop. Rate No. Pop. Rate No. Pop. Rate No. Pop. Rate No. Pop. Rate
0–4 1 150 912 0.1 0 124 404 0 1 67 560 0.3 0 65 958 0 0 24 297 0 0 25 134 0 0 28 023 0 0 59 595 0
5–9 1 168 576 0.1 0 132 408 0 0 66 114 0 1 66 396 0.2 0 23 616 0 1 25 368 0.7 0 27 903 0 0 62 340 0
10–14 2 177 069 0.2 1 149 223 0.1 0 62 805 0 0 66 390 0 0 21 699 0 0 25 020 0 0 29 160 0 0 65 322 0
15–19 0 160 299 0 1 153 717 0.1 0 49 527 0 0 58 344 0 0 18 126 0 0 22 854 0 1 37 326 0.5 0 65 340 0
20–29 14 305 277 0.5 7 247 842 0.3 4 82 254 0.9 2 80 610 0.4 1 33 768 0.5 1 34 638 0.5 0 65 388 0 1 150 300 0.1
30–39 13 396 915 0.5 23 314 730 1 2 77 574 0.4 5 77 847 1.3 0 31 749 0 5 33 690 2.4 0 70 500 0 2 151 791 0.3
40–49 41 397 581 1.5 59 352 290 2.2 4 57 951 1.2 3 69 024 0.8 1 21 804 0.8 4 27 204 2.3 3 60 066 2.3 2 158 523 0.5
50–59 59 334 500 2.9 91 306 990 4 3 33 300 1.5 6 42 687 2.4 3 13 311 4.7 0 17 043 0 3 37 320 1.4 3 119 442 0.4
60–69 65 231 972 4 85 224 982 5.3 2 19 488 1.8 3 22 947 2.2 0 7470 0 2 9645 4.2 2 23 544 1.5 2 70 539 0.5
o70 72 287 313 3.9 123 279 081 6.2 1 9702 1.7 2 12 888 2.7 0 4407 0 0 5700 0 0 21 099 0 6 49 335 11.2
Total 268 2 323 101 390 2 285 667 16 526 275 22 563 091 5 200 247 13 226 296 9 400 329 16 952 527
Age
standardized
rate
1.2# 1.7$ 0.8# 1$ 0.7# 1.2$ 0.5# 0.8#
* Mean annual incidence rate per 100 000.
Age-standardized rate per 100 000, standardized to the New Zealand population age structure of the 2001# and 2006$ census and World Health Organization world standard population.
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